Corrigendum to "HDL-C, triglycerides and carotid IMT: A meta-analysis of 21,000 patients with automated edge detection IMT measurement" [Atherosclerosis 232 (2014) 65-71]
1 From INSERM U 698, Paris, France; Paris Diderot e Sorbonne Paris City University, Paris, France; Department of Neurology and Stroke Centre, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France.
2 From INSERM U 698, Paris, France; Department of Neurology and Stroke Centre, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France.
3 Department of Endocrinology, Pitié-Salpêtrière University Hospital, Pierre and Marie Curie University, Paris, France.
4 Department of Cardiology, Buenos Aires Italian Hospital, Buenos Aires, Argentina.
5 Department of Neurology, "Gervasutta" Hospital ASS 4, Udine, Italy.
6 Department of Hematology, S. Bortolo Hospital, Vicenza, Italy.
7 Hypertension and Cardiovascular Risk Factors Clinic, Clinical Pharmacology Unit, School of Medicine, Universidad Centroccidental Lisandro Alvarado, Barquisimeto, Venezuela.
8 School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, People's Republic of China.
9 Department of Cardiology, Buenos Aires Italian Hospital, Buenos Aires, Argentina; InterAmerican Foundation for Clinical Research, New York, USA.
10 Paris Diderot e Sorbonne Paris City University, Paris, France; Department of Biostatistics, Fernand Widal Hospital, Paris, France.
11 From INSERM U 698, Paris, France; Paris Diderot e Sorbonne Paris City University, Paris, France; Department of Neurology and Stroke Centre, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France. Electronic address: pierre.amarenco@bch.aphp.fr.